Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Combinatorial Chemistry & High Throughput Screening
  4. Volume 28, Issue 1
  5. Article
Volume 28, Issue 1
  • ISSN: 1386-2073
  • E-ISSN: 1875-5402

Abstract

Background

Necroptosis, a recently identified mechanism of programmed cell death, exerts significant influence on various aspects of cancer biology, including tumor cell proliferation, stemness, metastasis, and immunosuppression. However, the role of necroptosis-related genes (NRGs) in Hepatocellular Carcinoma (HCC) remains elusive.

Methods

In this study, we assessed the mutation signature, copy number variation, and expression of 37 NRGs in HCC using the TCGA-LIHC dataset. We further validated our results using the ICGC-LIRI-JP dataset. To construct our prognostic model, we utilized the least absolute shrinkage and selection operator (LASSO), and evaluated the predictive efficacy of the NRGs-score using various machine learning algorithms, including K-M curves, time-ROC curves, univariate and multivariate Cox regression, and nomogram. In addition, we analyzed immune infiltration using the CIBERSOFT and ssGSEA algorithms, calculated the stemness index through the one-class logistic regression (OCLR) algorithm, and performed anti-cancer stem cells (CSCs) drug sensitivity analysis using oncoPredict. Finally, we validated the expression of the prognostic NRGs through qPCR both and .

Results

About 18 out of 37 NRGs were found to be differentially expressed in HCC and correlated with clinical outcomes. To construct a prognostic model, six signature genes (ALDH2, EZH2, PGAM5, PLK1, SQSTM1, and TARDBP) were selected using LASSO analysis. These genes were then employed to categorize HCC patients into two subgroups based on NRGs-score (low . high). A high NRGs score was associated with a worse prognosis. Furthermore, univariate and multivariate Cox regression analyses were performed to confirm the NRGs-score as an independent risk factor. These analyses revealed strong associations between NRGs-score and critical factors, such as AFP, disease stage, and tumor grade in the HCC cohort. NRGs-score effectively predicted the 1-, 3-, and 5-year survival of HCC patients. Immune infiltration analysis further revealed that the expression of immune checkpoint molecules was significantly enhanced in the high NRGs-score group. Stemness analysis in the HCC cohort showed that NRGs-score was positively correlated with mRNA stemness index, and patients with high NRGs-score were sensitive to CSCs inhibitors. The findings from the external validation cohort provided confirmation that the NRGs-score presented a trait with universal applicability in accurately predicting the survival of HCC. Additionally, the six prognostic genes were consistently differentially expressed in both the HCC cell line and the mouse HCC model.

Conclusion

Our study demonstrated the pivotal role of NRGs in promoting stemness and immune suppression in HCC and established a robust model which could successfully predict HCC prognosis.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cchts/10.2174/0113862073271292231108113547
2023-11-22
2025-01-19

  • From This Site

    /content/journals/cchts/10.2174/0113862073271292231108113547
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. KanwalF. SingalA.G. Surveillance for hepatocellular carcinoma: Current best practice and future direction.Gastroenterology20191571546410.1053/j.gastro.2019.02.049 30986389
     [Google Scholar]
  2. YangJ.D. HainautP. GoresG.J. AmadouA. PlymothA. RobertsL.R. A global view of hepatocellular carcinoma: Trends, risk, prevention and management.Nat. Rev. Gastroenterol. Hepatol.2019161058960410.1038/s41575‑019‑0186‑y 31439937
     [Google Scholar]
  3. CraigA.J. von FeldenJ. Garcia-LezanaT. SarcognatoS. VillanuevaA. Tumour evolution in hepatocellular carcinoma.Nat. Rev. Gastroenterol. Hepatol.202017313915210.1038/s41575‑019‑0229‑4 31792430
     [Google Scholar]
  4. TsuiY.M. ChanL.K. NgI.O.L. Cancer stemness in hepatocellular carcinoma: Mechanisms and translational potential.Br. J. Cancer2020122101428144010.1038/s41416‑020‑0823‑9 32231294
     [Google Scholar]
  5. LinC.C. MabeN.W. LinY.T. YangW.H. TangX. HongL. SunT. ForceJ. MarksJ.R. YaoT.P. AlvarezJ.V. ChiJ.T. RIPK3 upregulation confers robust proliferation and collateral cystine-dependence on breast cancer recurrence.Cell Death Differ.20202772234224710.1038/s41418‑020‑0499‑y 31988496
     [Google Scholar]
  6. SeifertL. WerbaG. TiwariS. Giao LyN.N. AlothmanS. AlqunaibitD. AvanziA. BarillaR. DaleyD. GrecoS.H. Torres-HernandezA. PergamoM. OchiA. ZambirinisC.P. PansariM. RendonM. TippensD. HundeyinM. ManiV.R. HajduC. EngleD. MillerG. The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression.Nature2016532759824524910.1038/nature17403 27049944
     [Google Scholar]
  7. WangW. MarinisJ.M. BealA.M. SavadkarS. WuY. KhanM. TaunkP.S. WuN. SuW. WuJ. AhsanA. KurzE. ChenT. YabohI. LiF. GutierrezJ. DiskinB. HundeyinM. ReillyM. LichJ.D. HarrisP.A. MahajanM.K. ThorpeJ.H. NassauP. MosleyJ.E. LeinwandJ. Kochen RossiJ.A. MishraA. AykutB. GlackenM. OchiA. VermaN. KimJ.I. VasudevarajaV. AdeegbeD. AlmonteC. BagdatliogluE. CohenD.J. WongK.K. BertinJ. MillerG. RIP1 kinase drives macrophage-mediated adaptive immune tolerance in pancreatic cancer.Cancer Cell202038458559010.1016/j.ccell.2020.09.020 33049209
     [Google Scholar]
  8. LiJ. LiaoD. WangF. WangZ. LiY. XiongY. NiuT. RIPK1 inhibition enhances the therapeutic efficacy of chidamide in FLT3-ITD positive AML, both in vitro and in vivo.Leuk. Lymphoma20226351167117910.1080/10428194.2021.2010056 34865571
     [Google Scholar]
  9. CaiZ. ZhangA. ChoksiS. LiW. LiT. ZhangX.M. LiuZ.G. Activation of cell-surface proteases promotes necroptosis, inflammation and cell migration.Cell Res.201626888690010.1038/cr.2016.87 27444869
     [Google Scholar]
  10. WangN. LiuD. Identification and validation a necroptosisrelated prognostic signature and associated regulatory axis in stomach adenocarcinoma.OncoTargets Ther.2021145373538310.2147/OTT.S342613
     [Google Scholar]
  11. LiY.T. ZhouN. DengW.X. ZengX.Z. WangX.J. PengJ.W. YangB. WangY.J. LiaoJ.Y. YinD. CIRDES: an efficient genome-wide method for in vivo RNA–RNA interactome analysis.Analyst (Lond.)2019144216197620610.1039/C9AN01054H 31441461
     [Google Scholar]
  12. RitchieM.E. PhipsonB. WuD. HuY. LawC.W. ShiW. SmythG.K. limma powers differential expression analyses for RNA-sequencing and microarray studies.Nucleic Acids Res.2015437e4710.1093/nar/gkv007 25605792
     [Google Scholar]
  13. KamarudinA.N. CoxT. Kolamunnage-DonaR. Time-dependent ROC curve analysis in medical research: current methods and applications.BMC Med. Res. Methodol.20171715310.1186/s12874‑017‑0332‑6 28388943
     [Google Scholar]
  14. MayakondaA. LinD.C. AssenovY. PlassC. KoefflerH.P. Maftools: Efficient and comprehensive analysis of somatic variants in cancer.Genome Res.201828111747175610.1101/gr.239244.118 30341162
     [Google Scholar]
  15. GuZ. GuL. EilsR. SchlesnerM. BrorsB. circlize implements and enhances circular visualization in R.Bioinformatics201430192811281210.1093/bioinformatics/btu393 24930139
     [Google Scholar]
  16. YuG. WangL.G. HanY. HeQ.Y. clusterProfiler: An R package for comparing biological themes among gene clusters.OMICS201216528428710.1089/omi.2011.0118 22455463
     [Google Scholar]
  17. KanehisaM. KEGG: Kyoto encyclopedia of genes and genomes.Nucleic Acids Res.20002812730
     [Google Scholar]
  18. DettoriJ.R. NorvellD.C. ChapmanJ.R. Seeing the forest by looking at the trees: How to interpret a meta-analysis forest plot.Global Spine J.202111461461610.1177/21925682211003889 33939533
     [Google Scholar]
  19. ZhangZ. KattanM.W. Drawing Nomograms with R: Applications to categorical outcome and survival data.Ann. Transl. Med.201751021110.21037/atm.2017.04.01 28603726
     [Google Scholar]
  20. HeY. JiangZ. ChenC. WangX. Classification of triple-negative breast cancers based on Immunogenomic profiling.J. Exp. Clin. Cancer Res.201837132710.1186/s13046‑018‑1002‑1 30594216
     [Google Scholar]
  21. MaltaT.M. SokolovA. GentlesA.J. BurzykowskiT. PoissonL. WeinsteinJ.N. KamińskaB. HuelskenJ. OmbergL. GevaertO. ColapricoA. CzerwińskaP. MazurekS. MishraL. HeynH. KrasnitzA. GodwinA.K. LazarA.J. StuartJ.M. HoadleyK.A. LairdP.W. NoushmehrH. WiznerowiczM. Caesar-JohnsonS.J. DemchokJ.A. FelauI. KasapiM. FergusonM.L. HutterC.M. SofiaH.J. TarnuzzerR. WangZ. YangL. ZenklusenJ.C. ZhangJ.J. ChudamaniS. LiuJ. LollaL. NareshR. PihlT. SunQ. WanY. WuY. ChoJ. DeFreitasT. FrazerS. GehlenborgN. GetzG. HeimanD.I. KimJ. LawrenceM.S. LinP. MeierS. NobleM.S. SaksenaG. VoetD. ZhangH. BernardB. ChambweN. DhankaniV. KnijnenburgT. KramerR. LeinonenK. LiuY. MillerM. ReynoldsS. ShmulevichI. ThorssonV. ZhangW. AkbaniR. BroomB.M. HegdeA.M. JuZ. KanchiR.S. KorkutA. LiJ. LiangH. LingS. LiuW. LuY. MillsG.B. NgK-S. RaoA. RyanM. WangJ. WeinsteinJ.N. ZhangJ. AbeshouseA. ArmeniaJ. ChakravartyD. ChatilaW.K. de BruijnI. GaoJ. GrossB.E. HeinsZ.J. KundraR. LaK. LadanyiM. LunaA. NissanM.G. OchoaA. PhillipsS.M. ReznikE. Sanchez-VegaF. SanderC. SchultzN. SheridanR. SumerS.O. SunY. TaylorB.S. WangJ. ZhangH. AnurP. PetoM. SpellmanP. BenzC. StuartJ.M. WongC.K. YauC. HayesD.N. ParkerJ.S. WilkersonM.D. AllyA. BalasundaramM. BowlbyR. BrooksD. CarlsenR. ChuahE. DhallaN. HoltR. JonesS.J.M. KasaianK. LeeD. MaY. MarraM.A. MayoM. MooreR.A. MungallA.J. MungallK. RobertsonA.G. SadeghiS. ScheinJ.E. SipahimalaniP. TamA. ThiessenN. TseK. WongT. BergerA.C. BeroukhimR. CherniackA.D. CibulskisC. GabrielS.B. GaoG.F. HaG. MeyersonM. SchumacherS.E. ShihJ. KucherlapatiM.H. KucherlapatiR.S. BaylinS. CopeL. DanilovaL. BootwallaM.S. LaiP.H. MaglinteD.T. Van Den BergD.J. WeisenbergerD.J. AumanJ.T. BaluS. BodenheimerT. FanC. HoadleyK.A. HoyleA.P. JefferysS.R. JonesC.D. MengS. MieczkowskiP.A. MoseL.E. PerouA.H. PerouC.M. RoachJ. ShiY. SimonsJ.V. SkellyT. SolowayM.G. TanD. VeluvoluU. FanH. HinoueT. LairdP.W. ShenH. ZhouW. BellairM. ChangK. CovingtonK. CreightonC.J. DinhH. DoddapaneniH.V. DonehowerL.A. DrummondJ. GibbsR.A. GlennR. HaleW. HanY. HuJ. KorchinaV. LeeS. LewisL. LiW. LiuX. MorganM. MortonD. MuznyD. SantibanezJ. ShethM. ShinbrotE. WangL. WangM. WheelerD.A. XiL. ZhaoF. HessJ. AppelbaumE.L. BaileyM. CordesM.G. DingL. FronickC.C. FultonL.A. FultonR.S. KandothC. MardisE.R. McLellanM.D. MillerC.A. SchmidtH.K. WilsonR.K. CrainD. CurleyE. GardnerJ. LauK. MalleryD. MorrisS. PaulauskisJ. PennyR. SheltonC. SheltonT. ShermanM. ThompsonE. YenaP. BowenJ. Gastier-FosterJ.M. GerkenM. LeraasK.M. LichtenbergT.M. RamirezN.C. WiseL. ZmudaE. CorcoranN. CostelloT. HovensC. CarvalhoA.L. de CarvalhoA.C. FregnaniJ.H. Longatto-FilhoA. ReisR.M. Scapulatempo-NetoC. SilveiraH.C.S. VidalD.O. BurnetteA. EschbacherJ. HermesB. NossA. SinghR. AndersonM.L. CastroP.D. IttmannM. HuntsmanD. KohlB. LeX. ThorpR. AndryC. DuffyE.R. LyadovV. PaklinaO. SetdikovaG. ShabuninA. TavobilovM. McPhersonC. WarnickR. BerkowitzR. CramerD. FeltmateC. HorowitzN. KibelA. MutoM. RautC.P. MalykhA. Barnholtz-SloanJ.S. BarrettW. DevineK. FulopJ. OstromQ.T. ShimmelK. WolinskyY. SloanA.E. De RoseA. GiulianteF. GoodmanM. KarlanB.Y. HagedornC.H. EckmanJ. HarrJ. MyersJ. TuckerK. ZachL.A. DeyarminB. HuH. KvecherL. LarsonC. MuralR.J. SomiariS. VichaA. ZelinkaT. BennettJ. IacoccaM. RabenoB. SwansonP. LatourM. LacombeL. TêtuB. BergeronA. McGrawM. StaugaitisS.M. ChabotJ. HibshooshH. SepulvedaA. SuT. WangT. PotapovaO. VoroninaO. DesjardinsL. MarianiO. Roman-RomanS. SastreX. SternM-H. ChengF. SignorettiS. BerchuckA. BignerD. LippE. MarksJ. McCallS. McLendonR. SecordA. SharpA. BeheraM. BratD.J. ChenA. DelmanK. ForceS. KhuriF. MaglioccaK. MaithelS. OlsonJ.J. OwonikokoT. PickensA. RamalingamS. ShinD.M. SicaG. Van MeirE.G. ZhangH. EijckenboomW. GillisA. KorpershoekE. LooijengaL. OosterhuisW. StoopH. van KesselK.E. ZwarthoffE.C. CalatozzoloC. CuppiniL. CuzzubboS. DiMecoF. FinocchiaroG. MatteiL. PerinA. PolloB. ChenC. HouckJ. LohavanichbutrP. HartmannA. StoehrC. StoehrR. TaubertH. WachS. WullichB. KyclerW. MurawaD. WiznerowiczM. ChungK. EdenfieldW.J. MartinJ. BaudinE. BubleyG. BuenoR. De RienzoA. RichardsW.G. KalkanisS. MikkelsenT. NoushmehrH. ScarpaceL. GirardN. AymerichM. CampoE. GinéE. GuillermoA.L. Van BangN. HanhP.T. PhuB.D. TangY. ColmanH. EvasonK. DottinoP.R. MartignettiJ.A. GabraH. JuhlH. AkeredoluT. StepaS. HoonD. AhnK. KangK.J. BeuschleinF. BreggiaA. BirrerM. BellD. BoradM. BryceA.H. CastleE. ChandanV. ChevilleJ. CoplandJ.A. FarnellM. FlotteT. GiamaN. HoT. KendrickM. KocherJ-P. KoppK. MoserC. NagorneyD. O’BrienD. O’NeillB.P. PatelT. PetersenG. QueF. RiveraM. RobertsL. SmallridgeR. SmyrkT. StantonM. ThompsonR.H. TorbensonM. YangJ.D. ZhangL. BrimoF. AjaniJ.A. GonzalezA.M.A. BehrensC. BondarukJ. BroaddusR. CzerniakB. EsmaeliB. FujimotoJ. GershenwaldJ. GuoC. LazarA.J. LogothetisC. Meric-BernstamF. MoranC. RamondettaL. RiceD. SoodA. TamboliP. ThompsonT. TroncosoP. TsaoA. WistubaI. CarterC. HayduL. HerseyP. JakrotV. KakavandH. KeffordR. LeeK. LongG. MannG. QuinnM. SawR. ScolyerR. ShannonK. SpillaneA. StretchJ. SynottM. ThompsonJ. WilmottJ. Al-AhmadieH. ChanT.A. GhosseinR. GopalanA. LevineD.A. ReuterV. SingerS. SinghB. TienN.V. BroudyT. MirsaidiC. NairP. DrwiegaP. MillerJ. SmithJ. ZarenH. ParkJ-W. HungN.P. KebebewE. LinehanW.M. MetwalliA.R. PacakK. PintoP.A. SchiffmanM. SchmidtL.S. VockeC.D. WentzensenN. WorrellR. YangH. MoncrieffM. GoparajuC. MelamedJ. PassH. BotnariucN. CaramanI. CernatM. ChemencedjiI. ClipcaA. DorucS. GorincioiG. MuraS. PirtacM. StanculI. TcaciucD. AlbertM. AlexopoulouI. ArnaoutA. BartlettJ. EngelJ. GilbertS. ParfittJ. SekhonH. ThomasG. RasslD.M. RintoulR.C. BifulcoC. TamakawaR. UrbaW. HaywardN. TimmersH. AntenucciA. FaccioloF. GraziG. MarinoM. MerolaR. de KrijgerR. Gimenez-RoqueploA-P. PichéA. ChevalierS. McKercherG. BirsoyK. BarnettG. BrewerC. FarverC. NaskaT. PennellN.A. RaymondD. SchileroC. SmolenskiK. WilliamsF. MorrisonC. BorgiaJ.A. LiptayM.J. PoolM. SederC.W. JunkerK. OmbergL. DinkinM. ManikhasG. AlvaroD. BragazziM.C. CardinaleV. CarpinoG. GaudioE. CheslaD. CottinghamS. DubinaM. MoiseenkoF. DhanasekaranR. BeckerK-F. JanssenK-P. Slotta-HuspeninaJ. Abdel-RahmanM.H. AzizD. BellS. CebullaC.M. DavisA. DuellR. ElderJ.B. HiltyJ. KumarB. LangJ. LehmanN.L. MandtR. NguyenP. PilarskiR. RaiK. SchoenfieldL. SenecalK. WakelyP. HansenP. LechanR. PowersJ. TischlerA. GrizzleW.E. SextonK.C. KastlA. HendersonJ. PortenS. WaldmannJ. FassnachtM. AsaS.L. SchadendorfD. CouceM. GraefenM. HulandH. SauterG. SchlommT. SimonR. TennstedtP. OlabodeO. NelsonM. BatheO. CarrollP.R. ChanJ.M. DisaiaP. GlennP. KelleyR.K. LandenC.N. PhillipsJ. PradosM. SimkoJ. Smith-McCuneK. VandenBergS. RogginK. FehrenbachA. KendlerA. SifriS. SteeleR. JimenoA. CareyF. ForgieI. MannelliM. CarneyM. HernandezB. CamposB. Herold-MendeC. JungkC. UnterbergA. von DeimlingA. BosslerA. GalbraithJ. JacobusL. KnudsonM. KnutsonT. MaD. MilhemM. SigmundR. GodwinA.K. MadanR. RosenthalH.G. AdebamowoC. AdebamowoS.N. BoussioutasA. BeerD. GiordanoT. Mes-MassonA-M. SaadF. BocklageT. LandrumL. MannelR. MooreK. MoxleyK. PostierR. WalkerJ. ZunaR. FeldmanM. ValdiviesoF. DhirR. LuketichJ. PineroE.M.M. Quintero-AguiloM. CarlottiC.G.Jr Dos SantosJ.S. KempR. SankarankutyA. TirapelliD. CattoJ. AgnewK. SwisherE. CreaneyJ. RobinsonB. ShelleyC.S. GodwinE.M. KendallS. ShipmanC. BradfordC. CareyT. HaddadA. MoyerJ. PetersonL. PrinceM. RozekL. WolfG. BowmanR. FongK.M. YangI. KorstR. RathmellW.K. Fantacone-CampbellJ.L. HookeJ.A. KovatichA.J. ShriverC.D. DiPersioJ. DrakeB. GovindanR. HeathS. LeyT. Van TineB. WesterveltP. RubinM.A. LeeJ.I. AredesN.D. MariamidzeA. Machine learning identifies stemness features associated with oncogenic dedifferentiation.Cell20181732338354.e1510.1016/j.cell.2018.03.034 29625051
     [Google Scholar]
  22. MaeserD. GruenerR.F. HuangR.S. oncoPredict: An R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data.Brief. Bioinform.2021226bbab26010.1093/bib/bbab260 34260682
     [Google Scholar]
  23. OrzalliM.H. KaganJ.C. Apoptosis and necroptosis as host defense strategies to prevent viral infection.Trends Cell Biol.2017271180080910.1016/j.tcb.2017.05.007 28642032
     [Google Scholar]
  24. BalachandranS. RallG.F. Benefits and perils of necroptosis in influenza virus infection.J. Virol.2020949e011011910.1128/JVI.01101‑19 32051270
     [Google Scholar]
  25. AllyA. BalasundaramM. CarlsenR. ChuahE. ClarkeA. DhallaN. HoltR.A. JonesS.J.M. LeeD. MaY. MarraM.A. MayoM. MooreR.A. MungallA.J. ScheinJ.E. SipahimalaniP. TamA. ThiessenN. CheungD. WongT. BrooksD. RobertsonA.G. BowlbyR. MungallK. SadeghiS. XiL. CovingtonK. ShinbrotE. WheelerD.A. GibbsR.A. DonehowerL.A. WangL. BowenJ. Gastier-FosterJ.M. GerkenM. HelselC. LeraasK.M. LichtenbergT.M. RamirezN.C. WiseL. ZmudaE. GabrielS.B. MeyersonM. CibulskisC. MurrayB.A. ShihJ. BeroukhimR. CherniackA.D. SchumacherS.E. SaksenaG. PedamalluC.S. ChinL. GetzG. NobleM. ZhangH. HeimanD. ChoJ. GehlenborgN. SaksenaG. VoetD. LinP. FrazerS. DefreitasT. MeierS. LawrenceM. KimJ. CreightonC.J. MuznyD. DoddapaneniH.V. HuJ. WangM. MortonD. KorchinaV. HanY. DinhH. LewisL. BellairM. LiuX. SantibanezJ. GlennR. LeeS. HaleW. ParkerJ.S. WilkersonM.D. HayesD.N. ReynoldsS.M. ShmulevichI. ZhangW. LiuY. IypeL. MakhloufH. TorbensonM.S. KakarS. YehM.M. JainD. KleinerD.E. JainD. DhanasekaranR. El-SeragH.B. YimS.Y. WeinsteinJ.N. MishraL. ZhangJ. AkbaniR. LingS. JuZ. SuX. HegdeA.M. MillsG.B. LuY. ChenJ. LeeJ-S. SohnB.H. ShimJ.J. TongP. AburataniH. YamamotoS. TatsunoK. LiW. XiaZ. StranskyN. SeiserE. InnocentiF. GaoJ. KundraR. ZhangH. HeinsZ. OchoaA. SanderC. LadanyiM. ShenR. AroraA. Sanchez-VegaF. SchultzN. KasaianK. RadenbaughA. BissigK-D. MooreD.D. TotokiY. NakamuraH. ShibataT. YauC. GraimK. StuartJ. HausslerD. SlagleB.L. OjesinaA.I. KatsonisP. KoireA. LichtargeO. HsuT-K. FergusonM.L. DemchokJ.A. FelauI. ShethM. TarnuzzerR. WangZ. YangL. ZenklusenJ.C. ZhangJ. HutterC.M. SofiaH.J. VerhaakR.G.W. ZhengS. LangF. ChudamaniS. LiuJ. LollaL. WuY. NareshR. PihlT. SunC. WanY. BenzC. PerouA.H. ThorneL.B. BoiceL. HuangM. RathmellW.K. NoushmehrH. SaggioroF.P. TirapelliD.P.C. JuniorC.G.C. MenteE.D. SilvaO.C.Jr TrevisanF.A. KangK.J. AhnK.S. GiamaN.H. MoserC.D. GiordanoT.J. VincoM. WellingT.H. CrainD. CurleyE. GardnerJ. MalleryD. MorrisS. PaulauskisJ. PennyR. SheltonC. SheltonT. KelleyR. ParkJ-W. ChandanV.S. RobertsL.R. BatheO.F. HagedornC.H. AumanJ.T. O’BrienD.R. KocherJ-P.A. JonesC.D. MieczkowskiP.A. PerouC.M. SkellyT. TanD. VeluvoluU. BaluS. BodenheimerT. HoyleA.P. JefferysS.R. MengS. MoseL.E. ShiY. SimonsJ.V. SolowayM.G. RoachJ. HoadleyK.A. BaylinS.B. ShenH. HinoueT. BootwallaM.S. Van Den BergD.J. WeisenbergerD.J. LaiP.H. HolbrookA. BerriosM. LairdP.W. Comprehensive and integrative genomic characterization of hepatocellular carcinoma.Cell2017169713271341.e2310.1016/j.cell.2017.05.046 28622513
     [Google Scholar]
  26. GalleP.R. FoersterF. KudoM. ChanS.L. LlovetJ.M. QinS. SchelmanW.R. ChintharlapalliS. AbadaP.B. ShermanM. ZhuA.X. Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma.Liver Int.201939122214222910.1111/liv.14223 31436873
     [Google Scholar]
  27. SamirP. MalireddiR.K.S. KannegantiT-D. The PANoptosome: A deadly protein complex driving pyroptosis, apoptosis, and necroptosis (PANoptosis).Front. Cell. Infect. Microbiol.20201023810.3389/fcimb.2020.00238
     [Google Scholar]
  28. KhemlinaG. IkedaS. KurzrockR. The biology of Hepatocellular carcinoma: implications for genomic and immune therapies.Mol. Cancer201716114910.1186/s12943‑017‑0712‑x 28854942
     [Google Scholar]
  29. LiuZ. LinY. GaoX. MaiR. PiaoX. YeJ. LiangR. Construction of a comprehensive multiomics map of hepatocellular carcinoma and screening of possible driver genes.Front. Genet.20201163410.3389/fgene.2020.00634
     [Google Scholar]
  30. HeY. YuX. LiJ. ZhangQ. ZhengQ. GuoW. Role of m5C-related regulatory genes in the diagnosis and prognosis of hepatocellular carcinoma.Am. J. Transl. Res.2020123912922 32269723
     [Google Scholar]
  31. LiY. ZengX. A novel cuproptosis-related prognostic gene signature and validation of differential expression in hepatocellular carcinoma.Front. Pharmacol.202213108195210.3389/fphar.2022.1081952
     [Google Scholar]
  32. TianL. YaoK. LiuK. HanB. DongH. ZhaoW. JiangW. QiuF. QuL. WuZ. ZhouB. ZhongM. ZhaoJ. QiuX. ZhongL. GuoX. ShiT. HongX. LuS. PLK1/NF-κB feedforward circuit antagonizes the mono-ADP-ribosyltransferase activity of PARP10 and facilitates HCC progression.Oncogene202039153145316210.1038/s41388‑020‑1205‑8 32060423
     [Google Scholar]
  33. ZhangH. FuL. The role of ALDH2 in tumorigenesis and tumor progression: Targeting ALDH2 as a potential cancer treatment.Acta Pharm. Sin. B20211161400141110.1016/j.apsb.2021.02.008 34221859
     [Google Scholar]
  34. MaX. YingY. XieH. LiuX. WangX. LiJ. The regulatory role of RNA metabolism regulator TDP-43 in human cancer.Front. Oncol.20211175509610.3389/fonc.2021.755096
     [Google Scholar]
  35. SeoW. GaoY. HeY. SunJ. XuH. FengD. ParkS.H. ChoY.E. GuillotA. RenT. WuR. WangJ. KimS.J. HwangS. LiangpunsakulS. YangY. NiuJ. GaoB. ALDH2 deficiency promotes alcohol-associated liver cancer by activating oncogenic pathways via oxidized DNA-enriched extracellular vesicles.J. Hepatol.20197151000101110.1016/j.jhep.2019.06.018 31279903
     [Google Scholar]
  36. GuoB. TanX. CenH. EZH2 is a negative prognostic biomarker associated with immunosuppression in hepatocellular carcinoma.PLoS One20201511e024219110.1371/journal.pone.0242191 33180829
     [Google Scholar]
  37. XiaoG. JinL.L. LiuC.Q. WangY.C. MengY.M. ZhouZ.G. ChenJ. YuX.J. ZhangY.J. XuJ. ZhengL. EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma.J. Immunother. Cancer20197130010.1186/s40425‑019‑0784‑9 31727135
     [Google Scholar]
  38. ChengJ. QianD. DingX. SongT. CaiM. DanXie WangY. ZhaoJ. LiuZ. WuZ. PangQ. ZhuL. WangP. HaoX. YuanZ. High PGAM5 expression induces chemoresistance by enhancing Bcl-xL-mediated anti-apoptotic signaling and predicts poor prognosis in hepatocellular carcinoma patients.Cell Death Dis.201891099110.1038/s41419‑018‑1017‑8 30250224
     [Google Scholar]
  39. SunW. SuQ. CaoX. ShangB. ChenA. YinH. LiuB. High expression of polo-like kinase 1 is associated with early development of hepatocellular carcinoma.Int. J. Genomics2014201431213010.1155/2014/312130
     [Google Scholar]
  40. FanW. MaH. JinB. Expression of FOXM1 and PLK1 predicts prognosis of patients with hepatocellular carcinoma.Oncol. Lett.202223514610.3892/ol.2022.13266 35350587
     [Google Scholar]
  41. Abdel-MoetyA. BaddourN. SalemP. El-TobgyH. El-ShendidiA. SQSTM1 expression in hepatocellular carcinoma and relation to tumor recurrence after radiofrequency ablation.J. Clin. Exp. Hepatol.202212377478410.1016/j.jceh.2021.12.001 35677515
     [Google Scholar]
  42. WangF. ZhangS. JeonR. VuckovicI. JiangX. LermanA. FolmesC.D. DzejaP.D. HerrmannJ. Interferon gamma induces reversible metabolic reprogramming of M1 macrophages to sustain cell viability and pro-inflammatory activity.EBioMedicine20183030331610.1016/j.ebiom.2018.02.009
     [Google Scholar]
  43. BaiK.H. HeS.Y. ShuL.L. WangW.D. LinS.Y. ZhangQ.Y. LiL. ChengL. DaiY.J. Identification of cancer stem cell characteristics in liver hepatocellular carcinoma by WGCNA analysis of transcriptome stemness index.Cancer Med.20209124290429810.1002/cam4.3047 32311840
     [Google Scholar]
  44. LeeT.K.W. GuanX.Y. MaS. Cancer stem cells in hepatocellular carcinoma — from origin to clinical implications.Nat. Rev. Gastroenterol. Hepatol.2022191264410.1038/s41575‑021‑00508‑3 34504325
     [Google Scholar]
  45. GongY. FanZ. LuoG. YangC. HuangQ. FanK. ChengH. JinK. NiQ. YuX. LiuC. The role of necroptosis in cancer biology and therapy.Mol. Cancer201918110010.1186/s12943‑019‑1029‑8 31122251
     [Google Scholar]
/content/journals/cchts/10.2174/0113862073271292231108113547
Loading
Establishment and Validation of the Novel Necroptosis-related Genes for Predicting Stemness and Immunity of Hepatocellular Carcinoma via Machine-learning Algorithm
Comb Chem High Throughput Screen 28, 146 (2025); https://doi.org/10.2174/0113862073271292231108113547
/content/journals/cchts/10.2174/0113862073271292231108113547
/content/journals/cchts/10.2174/0113862073271292231108113547
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Research Article
Keyword(s): cancer stemness; CSCs inhibitors sensitivity; hepatocellular carcinoma; Necroptosis; prognostic model; tumor immunity

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test